- Spectrophotometric plate readers, which enable high-throughput absorbance-based analysis of biological and chemical samples in microplates, are essential tools across pharmaceutical, biotech, academic, and clinical laboratories due to their speed, precision, and ability to streamline workflows in research and diagnostics
- The rising demand for spectrophotometric plate readers is primarily fueled by increasing investments in drug discovery and development, growing prevalence of chronic diseases, and the expanding need for accurate, automated sample analysis in laboratory settings
- North America dominated the spectrophotometric plate reader market with the largest revenue share of 42.1% in 2024, supported by strong R&D infrastructure, growing adoption of laboratory automation, and significant funding from government and private sectors—particularly in the U.S., where pharmaceutical and biotech companies are integrating next-generation analytical instruments for precision research
- Asia-Pacific is projected to be the fastest growing region in the spectrophotometric plate reader market during the forecast period, driven by rising healthcare expenditure, growing clinical research activities, and rapid development of academic and commercial laboratories across countries such as China and India
- Enzyme-linked immunosorbent assay segment dominated the market with a share of 47.3% in 2024, owing to its widespread application, cost-effectiveness, and compatibility with a wide range of assays including ELISA, protein quantification, and enzyme kinetics
